Amneal Pharmaceuticals Inc. (AMRX) has a current stock price of $4.38. During the previous trading session, the stock witnessed a notable rise, reaching a high of $4.39 after opening at $4.10. The stock’s low for the day was $4.03, and it eventually closed at $4.11.
Amneal Pharmaceuticals Inc.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $4.74 on 08/07/23, with the lowest value being $1.24 on 03/28/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of AMRX Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Amneal Pharmaceuticals Inc.’s current trading price is -7.59% away from its 52-week high, while its distance from the 52-week low is 253.23%. The stock’s price range during this period has fluctuated between $1.24 and $4.74. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.52 million for the day, which was evidently higher than the average daily volume of 1.17 million over the last three months.
Financial Performance and Market Capitalization
Amneal Pharmaceuticals Inc. (AMRX) has experienced a quarterly rise of 61.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.33B and boasts a workforce of 7600 employees.
Analysts’ Ratings For Amneal Pharmaceuticals Inc.
As of right now, 3 analysts are rating Amneal Pharmaceuticals Inc. as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.05, with a change in price of +2.67. Similarly, Amneal Pharmaceuticals Inc. recorded 1,075,420 in trading volume during the last 100 days, posting a change of +156.14%.
AMRX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AMRX stands at 8.81. Similarly, the long-term debt-to-equity ratio is also 8.33.
AMRX Stock Stochastic Average
Amneal Pharmaceuticals Inc.’s raw stochastic average for the past 50 days is currently at 79.89%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 98.67%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 74.71% and 64.24%, respectively.
AMRX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price gain of 120.10% this year. Over the last six months, there has been a weaker performance of 206.29%. The price of AMRX fallen by 18.38% during the last 30 days period. For the last 5-days stocks have improved 14.06%.
